(Q36969009)

17 August 2017

1 reference

title

Proteins, drug targets and the mechanisms they control: the simple truth about complex networks (English)

1 reference

17 August 2017

1 reference

1

Robyn P Araujo

1 reference

17 August 2017

Lance A Liotta

2

1 reference

PubMed ID

17932492

17 August 2017

Emanuel F Petricoin

series ordinal

3

1 reference

17 August 2017

1 November 2007

1 reference

Nature Reviews Drug Discovery

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

871-880

1 reference

17 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2381

17 August 2017

0 references

cites work

mTOR, a new therapeutic target in acute myeloid leukemia

1 reference

Gene expression profiling and clinical outcome in breast cancer

21 January 2018

1 reference

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

31 March 2020

1 reference

Multiplexed protein measurement: technologies and applications of protein and antibody arrays

31 March 2020

1 reference

Latest development in drug discovery on G protein-coupled receptors

31 March 2020

1 reference

Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments

31 March 2020

1 reference

Targeting proteases: successes, failures and future prospects

31 March 2020

1 reference

Can cell systems biology rescue drug discovery?

31 March 2020

1 reference

Cancer drugs. Smart weapons prove tough to design

31 March 2020

1 reference

Can't kick that oncogene habit

31 March 2020

1 reference

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

31 March 2020

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

31 March 2020

1 reference

Oncogene addiction: role of signal attenuation.

31 March 2020

1 reference

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

31 March 2020

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

31 March 2020

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

31 March 2020

1 reference

Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias

31 March 2020

1 reference

Resistance to targeted therapy in chronic myelogenous leukemia

31 March 2020

1 reference

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

31 March 2020

1 reference

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

31 March 2020

1 reference

A mathematical model of combination therapy using the EGFR signaling network

31 March 2020

1 reference

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

31 March 2020

1 reference

Strategies for optimizing combinations of molecularly targeted anticancer agents

31 March 2020

1 reference

Genomic and proteomic technologies for individualisation and improvement of cancer treatment

31 March 2020

1 reference

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

31 March 2020

1 reference

Clinical proteomics: revolutionizing disease detection and patient tailoring therapy

31 March 2020

1 reference

Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era

31 March 2020

1 reference

The GRID: the General Repository for Interaction Datasets

31 March 2020

1 reference

Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell

31 March 2020

1 reference

A control theoretic paradigm for cell signaling networks: a simple complexity for a sensitive robustness

31 March 2020

1 reference

Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine

31 March 2020

1 reference

The impact of systems approaches on biological problems in drug discovery

31 March 2020

1 reference

Irreversible cell-cycle transitions are due to systems-level feedback.

31 March 2020

1 reference

A systems- and signal-oriented approach to intracellular dynamics

31 March 2020

1 reference

Understanding biology by reverse engineering the control

31 March 2020

1 reference

EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation

31 March 2020

1 reference

Signaling networks: the origins of cellular multitasking

31 March 2020

1 reference

Modeling of protein signaling networks in clinical proteomics

31 March 2020

1 reference

Systems biology. Less is more in modeling large genetic networks.

31 March 2020

1 reference

Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs

31 March 2020

1 reference

An amplified sensitivity arising from covalent modification in biological systems

31 March 2020

1 reference

Quantitative analysis of signaling networks.

31 March 2020

1 reference

Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems

31 March 2020

1 reference

A positive-feedback-based bistable 'memory module' that governs a cell fate decision

31 March 2020

1 reference

Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible

31 March 2020

1 reference

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

31 March 2020

1 reference

PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells

31 March 2020

1 reference

Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101)

31 March 2020

1 reference

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

31 March 2020

1 reference

Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function

31 March 2020

1 reference

Restraining PI3K: mTOR signalling goes back to the membrane.

31 March 2020

1 reference

An expanding role for mTOR in cancer

31 March 2020

1 reference

The Hill equation revisited: uses and misuses.

31 March 2020

1 reference

PI3K/Akt/mTOR pathway as a target for cancer therapy

31 March 2020

1 reference

Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance

31 March 2020

1 reference

Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation

31 March 2020

1 reference

The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

31 March 2020

1 reference

31 March 2020

SnapShot: mTOR signaling

1 reference

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

31 March 2020

1 reference

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

31 March 2020

1 reference

Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.

31 March 2020

1 reference

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

31 March 2020

1 reference

Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells

31 March 2020

1 reference

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

31 March 2020

1 reference

Drug resistance in cancer: principles of emergence and prevention

31 March 2020

1 reference

Emergence and prevention of resistance against small molecule inhibitors

31 March 2020

1 reference

Calculated resistance in cancer.

31 March 2020

1 reference

Virus dynamics and drug therapy

31 March 2020

1 reference

Production of resistant HIV mutants during antiretroviral therapy

31 March 2020

1 reference

Current status of mammalian target of rapamycin inhibitors in lung cancer

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD2381

1 reference

17 August 2017

1 reference

PubMed ID

17932492